Current Oncology (Dec 2022)

Reconstruction after Talar Tumor Resection: A Systematic Review

  • Shinji Tsukamoto,
  • Andreas F. Mavrogenis,
  • Kanya Honoki,
  • Akira Kido,
  • Yuu Tanaka,
  • Hiromasa Fujii,
  • Yoshinori Takakura,
  • Yasuhito Tanaka,
  • Costantino Errani

DOI
https://doi.org/10.3390/curroncol29120769
Journal volume & issue
Vol. 29, no. 12
pp. 9788 – 9800

Abstract

Read online

This systematic review investigated the functional outcomes and complications of reconstruction methods after talar tumor resection. A systematic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials databases identified 156 studies, of which 20 (23 patients) were ultimately included. The mean Musculoskeletal Tumor Society scores in the groups reconstructed using tibiocalcaneal fusion (n = 17), frozen autograft (n = 1), and talar prosthesis (n = 5) were 77.6 (range 66–90), 70, and 90 (range 87–93), respectively. Regarding complications, sensory deficits were observed in one patient (6%) and venous thrombosis in two patients (12%) in the tibiocalcaneal fusion group, while osteoarthritis was observed in one patient (100%) in the frozen autograft group. No complications were observed in the talar prosthesis group. Reconstruction with talar prosthesis seems preferable to conventional tibiocalcaneal fusion after talar tumor resection because it offers better function and fewer complications. However, as this systematic review included only retrospective studies with a small number of patients, its results require re-evaluation in future randomized controlled trials with larger numbers of patients.

Keywords